These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of the distribution of methotrexate in the sting rays Dasyatidae sabrina and sayi by use of a model developed in mice. Zaharko DS; Dedrick RL; Oliverio VT Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):183-94. PubMed ID: 4402707 [No Abstract] [Full Text] [Related]
3. Tissue distribution of folate antagonists. Oliverio VT; Zaharko DS Ann N Y Acad Sci; 1971 Nov; 186():387-99. PubMed ID: 4943809 [No Abstract] [Full Text] [Related]
8. [Mathematical models of pharmacokinetics in chemotherapy]. Soloviev V; Fishman VM; Firsov AA Pharmazie; 1976; 31(12):825-39. PubMed ID: 799315 [No Abstract] [Full Text] [Related]
9. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. Furst DE J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():11-4. PubMed ID: 3913770 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic studies of methotrexate in cancer patients with uropathy. Ojima Y; Anderson LL; Collins GJ; Oberfield RA; Sullivan RD Arch Surg; 1970 Feb; 100(2):173-7. PubMed ID: 5411410 [No Abstract] [Full Text] [Related]
11. Absorption, distribution and urinary excretion of creatinol O-phosphate ( 14 C) in the guinea-pig. Marzo A; Ghirardi P; Croce G; Marchetti G Arch Int Pharmacodyn Ther; 1971 Aug; 192(2):378-92. PubMed ID: 5093207 [No Abstract] [Full Text] [Related]
12. A study of the distribution of methotrexate in human tissues and tumors. Anderson LL; Collins GJ; Ojima Y; Sullivan RD Cancer Res; 1970 May; 30(5):1344-8. PubMed ID: 5426936 [No Abstract] [Full Text] [Related]
13. Effect of route of administration and effusions on methotrexate pharmacokinetics. Wan SH; Huffman DH; Azarnoff DL; Stephens R; Hoogstraten B Cancer Res; 1974 Dec; 34(12):3487-91. PubMed ID: 4429965 [No Abstract] [Full Text] [Related]
14. Hepatic uptake, intracellular protein binding and biliary excretion of amethopterin. Strum WB; Liem HH Biochem Pharmacol; 1977 Jul; 26(13):1235-40. PubMed ID: 880268 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics and organ distribution of methotrexate in the rat. Scheufler E; Zetler G; Iven H Pharmacology; 1981; 23(2):75-81. PubMed ID: 7312939 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of methotrexate. Huffman DH; Wan SH; Azarnoff DL; Hogstraten B Clin Pharmacol Ther; 1973; 14(4):572-9. PubMed ID: 4723265 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species. Dedrick RL; Forrester DD; Cannon JN; el-Dareer SM; Mellett LB Biochem Pharmacol; 1973 Oct; 22(19):2405-17. PubMed ID: 4200888 [No Abstract] [Full Text] [Related]
18. [Effect and istribution of methotrexate in the human organism during leukemia treatment]. Wilmanns W; Martin H Klin Wochenschr; 1968 Mar; 46(6):281-96. PubMed ID: 5245556 [No Abstract] [Full Text] [Related]
19. Compartmental study on the pharmacokinetics of D-penicillamine. Polig E; Planas-Bohne F Biophysik; 1973; 10(4):321-36. PubMed ID: 4791126 [No Abstract] [Full Text] [Related]
20. Clinical pharmacokinetics of methotrexate in psoriasis therapy. Hendel J Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004 [No Abstract] [Full Text] [Related] [Next] [New Search]